Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The gelatin sponge sheet formulation used by Tianjin Medical University Eye Hospital is a multi-component surgical packing material employed during endoscopic dacryocystorhinostomy (En-DCR) for the treatment of chronic dacryocystitis. This combination product consists of a biodegradable gelatin sponge matrix that is covered or impregnated with thrombin, tobramycin, and dexamethasone ophthalmic ointment. The gelatin sponge provides a physical scaffold for hemostasis, while thrombin acts as a topical coagulant by converting fibrinogen into fibrin. Tobramycin, an aminoglycoside antibiotic, is included to provide broad-spectrum antibacterial prophylaxis against surgical site infections. Dexamethasone, a potent corticosteroid, is utilized to suppress the postoperative inflammatory response and minimize the formation of granulation tissue and membranous adhesions at the anastomosis site, which are the primary causes of surgical failure. In clinical trial settings, this specific packing protocol serves as a standard-of-care control to evaluate the safety and efficacy of newer packing materials like hydroxybutyl chitosan.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gelatin sponge sheet.